Development of a peptide targeting dopamine transporter to improve ADHD-like deficits
Abstract Attention-deficit hyperactivity disorder (ADHD) is a neurocognitive disorder characterized by hyperactivity, inattention, working memory deficits and impulsivity. Its worldwide prevalence is estimated to be 3–5% in children and adolescents. The mainstay treatment for ADHD is stimulant medic...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-11-01
|
| Series: | Molecular Brain |
| Online Access: | http://link.springer.com/article/10.1186/s13041-018-0409-0 |